Grupo de investigación traslacional vascular y renal

Lecube, A.; Sanchez, E.; Betriu, A.; Gutierrez-Carrasquilla, L.; Elias, M.; Barbe, F.; Purroy, F.; Buti, M.; Fernandez, E.; Lopez-Cano, C.

Impaired pulmonary function in type 2 diabetes: Is there a role for advanced glycation end-products measured by skin autofluorescence?Data form the ILERVAS project

Diabetologia 60 503-503. 01/09/2017.

Bermudez-Lopez, M; Arroyo, D; Betriu À; Masana, L; Fernandez, E; Valdivielso, JM

New perspectives on CKD-induced dyslipidemia

Expert Opinion On Therapeutic Targets 21 967-976. 28/08/2017.

[doi:10.1080/14728222.2017.1369961]

Hernandez, M; Lopez, C; Real, J; Valls, J; Ortega-Martinez de Victoria E; Vazquez, F; Rubinat, E; Granado-Casas, M; Alonso, N; Moli, T; Betriu, A; Lecube, A; Fernandez, E; Leslie, RD; Mauricio, D

Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes

Cardiovascular Diabetology 16 94-94. 28/07/2017.

[doi:10.1186/s12933-017-0576-9]

Elvira Fernández; Mª Paz Marco

Desafíos de la Nefrología en pacientes con VIH / SIDA

VIH en España 2017: Políticas para una nueva gestión de la cronicidad, más allá del control virológico Cap 6 143-161. 13/06/2017.

Vilanova, MB; Falguera, M; Marsal, JR; Rubinat, E; Alcubierre, N; Catelblanco, E; Granado-Casas, M; Miro, N; Mollo, A; Mata-Cases, M; Franch-Nadal, J; Mauricio, D

Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study

Bmj Open 7 -. 01/06/2017.

[doi:10.1136/bmjopen-2016-015158]

Gracia, M; Betriu, A; Martinez, M; Arroyo, D; Abajo, M; Fernandez, E; Valdivielso, JM

KLOTHO GENE POLYMORPHISMS ARE ASSOCIATED WITH PROGRESSION OF ATHEROMATOSIS IN PATIENTS WITH CKD. RESULTS OF TWO YEARS FOLLOW-UP OF THE NEFRONA COHORT

NEPHROLOGY DIALYSIS TRANSPLANTATION 32 -. 01/05/2017.

Fernandez-Laso, V; Mendez-Barbero, N; Valdivielso, JM; Betriu, A; Fernandez, E; Egido, J; Martin-Ventura, JL; Blanco-Colio, LM

Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease

Atherosclerosis 260 130-137. 01/05/2017.

[doi:10.1016/j.atherosclerosis.2017.03.043]

Carmona, A; Aguera, ML; Luna-Ruiz, C; Buendia, P; Calleros, L; Garcia-Jerez, A; Rodriguez-Puyol, M; Arias, M; Arias-Guillen, M; de Arriba, G; Ballarin, J; Bernis, C; Fernandez, E; Garcia-Rebollo, S; Mancha, J; del Peso, G; Perez, E; Poch, E; Portoles, JM; Rodriguez-Puyol, D; Sanchez-Villanueva, R; Sarro, F; Torres, A; Martin-Malo, A; Aljama, P; Ramirez, R; Carracedo, J

Markers of endothelial damage in patients with chronic kidney disease on hemodialysis

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY 312 673-681. 01/04/2017.

[doi:10.1152/ajprenal.00013.2016]

Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E

Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study

NEPHROLOGY DIALYSIS TRANSPLANTATION 32 513-520. 01/03/2017.

[doi:10.1093/ndt/gfw039]

Sanchez, E; Betriu À; Arroyo, D; Lopez, C; Hernandez, M; Rius, F; Fernandez, E; Lecube, A

Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study

PLOS ONE 12 -. 31/01/2017.

[doi:10.1371/journal.pone.0170778]

Torremade, N; Bozic, M; Goltzman, D; Fernandez, E; Valdivielso, JM

Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase

PLOS ONE 12 -. 20/01/2017.

[doi:10.1371/journal.pone.0170654]

Arcidiacono, MV; Martinez-Alonso, M; Belart, M; Vilar, A; Martin, M; Craver, L; Betriu À; Mauricio, D; Valdivielso, JM; Fernandez, E; Borràs M

High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease

Mediators of Inflammation 2017 3795142-3795142. 01/01/2017.

[doi:10.1155/2017/3795142]